Matthew Foy

Director/Board Member at

Pulmocide Ltd.

Health Technology

Finance

Consumer Services

Profile

Mr. Matthew Foy is an Investor at Asceneuron SA and a Partner at GSK Equity Investments Ltd. He is on the Board of Directors at Akamis Bio Ltd., Fore Biotherapeutics, Inc. and Pulmocide Ltd. Mr. Foy was previously employed as an Independent Director by Decibel Therapeutics, Inc., an Operating Partner by SR One Capital Management LP, a Vice President by Greenhill & Co., Inc., and a Consultant by Longbow Capital Partners LP.
He also served on the board at Progenitor Labs Ltd., Atox Bio Ltd. and Puridify Ltd. He received his undergraduate degree from the University of Oxford, an undergraduate degree from St Peters College Oxford, a graduate degree from the University of Oxford and a graduate degree from St Peters College Oxford.

Matthew Foy active positions

Companies	Position	Start
GSK Equity Investments Ltd. GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements.	Private Equity Investor	01/01/2011
Akamis Bio Ltd. Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies	Director/Board Member	-
Pulmocide Ltd. Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases	Director/Board Member	-
Fore Biotherapeutics, Inc. Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies	Director/Board Member	-
Asceneuron SA Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders	Private Equity Investor	01/09/2015

All active positions of Matthew Foy

Former positions of Matthew Foy

Companies	Position	End
Progenitor Labs Ltd. Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing	Director/Board Member	25/07/2018
Puridify Ltd. Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Develops bioprocessing technologies	Director/Board Member	24/11/2017
GREENHILL & CO., INC.	Corporate Officer/Principal	01/01/2010
SR One Capital Management LP SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements.	Private Equity Investor	-
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Matthew Foy's experience

Training of Matthew Foy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Foy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
GSK Equity Investments Ltd. GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements.	Finance
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Greenhill & Co., Inc. Greenhill & Co., Inc. Investment Banks/BrokersFinance Operates as an investment bank that provides financial advisory services	Finance
Longbow Capital Partners LP Longbow Capital Partners LP Investment ManagersFinance Longbow is a long/short investment firm focused on investing primarily in the equity securities of companies within the utility, power, energy midstream and related infrastructure sectors. The firm seeks superior risk-adjusted, investment returns with low correlation to the equity market.	Finance
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections	Health Technology
Akamis Bio Ltd. Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies	Health Technology
St Peters College Oxford St Peters College Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Progenitor Labs Ltd. Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing	Health Technology
Asceneuron SA Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders	Health Technology
Pulmocide Ltd. Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases	Health Technology
Puridify Ltd. Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Develops bioprocessing technologies	Commercial Services
Decibel Therapeutics, Inc. Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders	Health Technology
Fore Biotherapeutics, Inc. Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies	Health Technology
SR One Capital Management LP SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements.	Finance